
Photo taken from Andres Gomez/X
Feb 26, 2024, 17:54
Andres Gomez: Retrospective data continues to favor haploidentical in adults with Acute Lymphocytic Leukemia
Andres Gomez, Associate Professor at the Autonomous University of Nuevo León, recently posted on X/Twitter:
“Retrospective data continues to favor haplo in adults with ALL.
No need for a MUD if you have a good haplo, an experienced team, and a good infrastructure.
Poster 132 Tandem23 outcomes in SoCal single center(n=118).”
Source: Andres Gomez/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 27, 2025, 17:56
Feb 27, 2025, 17:55
Feb 27, 2025, 17:54
Feb 27, 2025, 17:53
Feb 27, 2025, 17:49
Feb 27, 2025, 17:46
Feb 27, 2025, 17:13
Feb 27, 2025, 17:10